Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ILMN

Illumina Inc

Jul 26 • 04:00PM ET

120.43

Dollar change +3.13
Percentage change 2.67	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IJH VTI QQQ VO VXF VUG MDY IBB VOT IJJ

Scroll to Statements

Index	NDX	P/E	-	EPS (ttm)	-8.15	Insider Own	0.52%	Shs Outstand	159.00M	Perf Week	5.19%
Market Cap	19.18B	Forward P/E	36.52	EPS next Y	3.30	Insider Trans	0.89%	Shs Float	158.47M	Perf Month	13.96%
Income	-1290.00M	PEG	-	EPS next Q	0.11	Inst Own	91.97%	Short Float	3.01%	Perf Quarter	2.37%
Sales	4.49B	P/S	4.27	EPS this Y	27.17%	Inst Trans	2.72%	Short Ratio	1.76	Perf Half Y	-13.20%
Book/sh	36.06	P/B	3.34	EPS next Y	210.22%	ROA	-11.81%	Short Interest	4.78M	Perf Year	-35.18%
Cash/sh	7.00	P/C	17.21	EPS next 5Y	76.60%	ROE	-20.76%	52W Range	86.49 - 190.13	Perf YTD	-11.00%
Dividend Est.	-	P/FCF	52.56	EPS past 5Y	-	ROI	-16.28%	52W High	-36.66%	Beta	1.13
Dividend TTM	-	Quick Ratio	1.36	Sales past 5Y	7.40%	Gross Margin	61.38%	52W Low	39.24%	ATR (14)	4.71
Dividend Ex-Date	-	Current Ratio	1.75	EPS Y/Y TTM	71.48%	Oper. Margin	-1.51%	RSI (14)	60.86	Volatility	4.17% 3.92%
Employees	12010	Debt/Eq	0.40	Sales Y/Y TTM	1.03%	Profit Margin	-28.71%	Recom	2.19	Target Price	140.16
Option/Short	Yes / Yes	LT Debt/Eq	0.38	EPS Q/Q	-4270.53%	Payout	-	Rel Volume	0.53	Prev Close	117.30
Sales Surprise	2.44%	EPS Surprise	109.83%	Sales Q/Q	-1.01%	Earnings	Aug 06 AMC	Avg Volume	2.72M	Price	120.43
SMA20	6.76%	SMA50	11.02%	SMA200	0.92%	Trades		Volume	1,453,266	Change	2.67%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$140
Jun-03-24	Resumed	Jefferies	Hold	$115
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170
Dec-14-23	Initiated	Guggenheim	Buy	$155
Dec-13-23	Initiated	Wolfe Research	Outperform	$175
Dec-12-23	Downgrade	BofA Securities	Neutral → Underperform	$140 → $100
Dec-11-23	Upgrade	Citigroup	Sell → Neutral	$85 → $120
Nov-10-23	Downgrade	Canaccord Genuity	Buy → Hold	$210 → $120
Sep-28-23	Initiated	Bernstein	Underperform	$111
Jul-05-23	Resumed	JP Morgan	Neutral	$235
Jan-25-23	Downgrade	Argus	Buy → Hold
Jan-05-23	Initiated	Scotiabank	Sector Perform	$216
Dec-12-22	Downgrade	Citigroup	Neutral → Sell	$200 → $180
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$282
Oct-04-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$220 → $270
Sep-28-22	Upgrade	Evercore ISI	In-line → Outperform	$170 → $250

Show Previous Ratings

Jul-24-24 08:55AM	Heres Why You Should Add Illumina (ILMN) to Your Portfolio (Insider Monkey)
Jul-22-24 12:10PM	Why Illumina (ILMN) Could Beat Earnings Estimates Again (Zacks)
09:55AM	Wall Street Analysts Think Illumina (ILMN) Could Surge 27.02%: Read This Before Placing a Bet (Zacks)
Jul-21-24 11:49PM	10x Genomics, Inc. (TXG): Hedge Funds Think This Stock Will Skyrocket (Insider Monkey)
06:00AM	3 Precision Medicine Stocks Tailoring Treatments (InvestorPlace)
03:02AM	Loading…
Jul-19-24 03:02AM	Should You Consider Adding Illumina (ILMN) to Your Portfolio? (Insider Monkey)
Jul-18-24 04:05PM	Illumina to Present Upcoming Strategy Update (PR Newswire)
Jul-16-24 07:51PM	Analyst Report: Illumina, Inc. (Morningstar Research) +7.44%
12:00PM	Illumina (ILMN) Upgraded to Buy: Here's Why (Zacks)
Jul-15-24 12:31PM	3 Spinoff Stocks You Should Buy Now: July 2024 (InvestorPlace)
Jul-12-24 07:45AM	Element raises $277M to challenge Illumina in sequencing market (MedTech Dive)
06:32AM	Illumina sees stock spike after acquisition of Fluent BioSciences (Medical Device Network)
Jul-11-24 04:05PM	Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 (PR Newswire)
Jul-10-24 02:10PM	Illumina Deal Sends 10x Genomics Stock Tumbling (Barrons.com) +6.08%
10:53AM	Illumina (ILMN) Buys Fluent, Grows in Single Cell Research (Zacks)
12:51AM	Loading…
12:51AM	Illumina buys Fluent Biosciences, adding single-cell analysis tech (MedTech Dive)
Jul-09-24 04:05PM	Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base (PR Newswire)
03:22PM	3 Of the Best ETFs to Buy for AI Stocks Exposure (InvestorPlace)
Jul-08-24 09:00AM	The 3 Best Gene Editing Stocks to Buy in July 2024 (InvestorPlace)
Jul-05-24 06:55AM	3 Biotech Stocks Turning DNA Dreams Into Dollars (InvestorPlace)
Jul-03-24 07:00AM	The 3 Best Personalized Medicine Stocks to Buy in July 2024 (InvestorPlace)
Jun-28-24 11:00AM	Illumina Takes a $1.47 Billion Charge Related to Its GRAIL Spinoff (Investopedia)
Jun-25-24 11:26AM	Illumina (ILMN) Rises on Conclusion of GRAIL Divestment (Zacks)
11:12AM	GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today (InvestorPlace)
10:41AM	Analyst Report: Illumina, Inc. (Morningstar Research)
Jun-24-24 05:05PM	Illumina Finishes Spinning Off Cancer-Test Maker Grail (The Wall Street Journal)
04:05PM	Illumina completes the divestiture of GRAIL (PR Newswire)
04:05PM	GRAIL to Begin Trading on the Nasdaq Stock Exchange (Business Wire)
Jun-20-24 12:30PM	3 Stocks to Buy That Are NOT in the S&P 500 (but Should Be) (InvestorPlace)
Jun-17-24 06:15AM	The Watchlist: 3 Stock Spinoffs Coming Soon (Be Ready to Buy) (InvestorPlace)
10:49AM	Loading…
Jun-12-24 10:49AM	Illumina (ILMN) Advances in NGS With DRAGEN v4.3 Launch (Zacks)
09:45AM	Video: Illumina Employees Share Their 'Why' (ACCESSWIRE)
Jun-11-24 09:15AM	Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations (PR Newswire)
Jun-10-24 04:45PM	S&P 500 Gains and Losses Today: Southwest Airlines Soars as Activist Pushes for Change (Investopedia)
04:24PM	CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump (Investor's Business Daily)
02:51PM	CrowdStrike, KKR, GoDaddy Stocks Rally Ahead of S&P 500 Inclusion (The Wall Street Journal)
02:43PM	Here's Why Stocks Such as CrowdStrike and KKR Jumped Today, Whereas Stocks Such as Illumina Dropped (Motley Fool)
12:57PM	Top Stock Movers Now: Southwest Airlines, Planet Fitness, AMD, and More (Investopedia)
11:37AM	KKR Stock Pops 10% on June 21 Inclusion in the S&P 500 (InvestorPlace)
11:12AM	GDDY Stock Alert: GoDaddy Will Join the S&P 500 on June 21 (InvestorPlace)
10:12AM	KKR, CrowdStrike, and GoDaddy Gain on S&P 500 Inclusion (Investopedia)
07:34AM	5 Things to Know Before the Stock Market Opens (Investopedia)
Jun-07-24 06:09PM	KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
05:28PM	U.S. Rep. Thomas Kean Jr. Just Bought Illumina Stock and Sold Nike Stock. Should You Do the Same? (Motley Fool)
Jun-06-24 05:24PM	S&P 500 Gains and Losses Today: Illumina Stock Jumps After Grail Spinoff News (Investopedia) +7.42%
Jun-05-24 07:47AM	Illumina marked for growth following completion of Grail spinout (Medical Device Network)
04:50AM	Is It Time to Buy May's Worst-Performing S&P 500 Stocks? (Motley Fool)
Jun-04-24 09:15AM	Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost (PR Newswire)
08:19AM	Illumina board approves Grail spinoff (MedTech Dive)
07:06AM	Illumina names Everett Cunningham as chief commercial officer (MedTech Dive)
Jun-03-24 11:45PM	Futures lower, JOLTS ahead, GameStop surges - what's moving markets (Investing.com)
10:07PM	Analyst Report: Illumina, Inc. (Morningstar Research)
05:41PM	Illumina's board approves to spin off Grail in June (Reuters)
05:22PM	Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares (PR Newswire)
07:11AM	Illumina appoints Everett Cunningham Chief Commercial Officer (PR Newswire)
May-29-24 09:15AM	Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO (PR Newswire)
07:07AM	7 Large-Cap Stocks That Can Jump 50% By 2025 (InvestorPlace)
May-28-24 04:05PM	Illumina releases 2023 Corporate Social Responsibility Report (PR Newswire)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
May-24-24 10:28AM	Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok (The Wall Street Journal)
May-20-24 04:05PM	Anna Richo joins Illumina's Board of Directors (PR Newswire)
May-15-24 04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
05:58AM	Daiwa Securities Adjusts Price Target on Illumina to $120 From $133 (MT Newswires)
May-13-24 12:22PM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:45AM	Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 06:00AM	Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life (InvestorPlace)
May-07-24 07:15AM	Illumina Files Registration Statement for Planned GRAIL Divestiture (MT Newswires) -5.18%
May-06-24 06:28PM	Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL (PR Newswire)
May-03-24 11:55AM	Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:46AM	Bernstein Adjusts Illumina's Price Target to $130 From $129 (MT Newswires)
10:46AM	TD Cowen Adjusts Illumina's Price Target to $140 From $150 (MT Newswires)
10:20AM	Baird Raises Price Target on Illumina to $128 From $125 (MT Newswires)
09:39AM	Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens (Zacks)
09:25AM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
09:18AM	Evercore ISI Adjusts Price Target on Illumina to $195 From $200 (MT Newswires)
07:16AM	Q1 2024 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
06:55AM	Leerink Adjusts Price Target on Illumina to $150 From $155 (MT Newswires)
04:12AM	Illumina Inc (ILMN) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-02-24 09:46PM	Analyst Report: Illumina, Inc. (Morningstar Research)
08:56PM	ILMN Stock Earnings: Illumina Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:30PM	Illumina (ILMN) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
06:25PM	Illumina reaffirms annual revenue forecast over continued sluggish demand (Reuters)
05:35PM	Illumina Inc (ILMN) Q1 Earnings: Navigating Through Challenges with Mixed Results (GuruFocus.com)
05:21PM	Illumina Q1 Non-GAAP Earnings Increase, Revenue Decreases -- Shares Down After Hours (MT Newswires)
04:17PM	Illumina: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for First Quarter of Fiscal Year 2024 (PR Newswire)
06:04AM	3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace)
Apr-29-24 09:09PM	Lightning Round: Illumina is a good company that's poorly run, says Jim Cramer (CNBC TV)
12:45PM	Inspiring Young Minds: HRH the Princess Royal Helps Illumina Celebrate DNA Day (ACCESSWIRE)
09:16AM	Gear Up for Illumina (ILMN) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Apr-26-24 06:03AM	Shein to face tougher online content rules as EU designates it as very large online platform (Reuters)
Apr-25-24 10:02AM	Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:53AM	20 Countries with the Highest Rates of Stomach Cancer in the World (Insider Monkey)
Apr-21-24 08:30AM	This CEO has battled billionaire activist Carl Icahn twice here's his advice to Disney CEO Bob Iger (Yahoo Finance)
Apr-19-24 02:05PM	20 Countries with the Highest Cancer Survival Rates in the World (Insider Monkey)
12:10PM	Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive? (Zacks)
Apr-18-24 01:30PM	Engineering a Cool Career in Biotech - and Volunteering Along the Way (ACCESSWIRE)
08:00AM	QQQ Has Some Inexpensive Growth Stocks (ETF Trends)
Apr-17-24 09:30AM	Evidence Supports Sequencing As First-Line Rare Disease Diagnostic (ACCESSWIRE)
Apr-15-24 05:40AM	European Commission approves Illuminas proposed Grail split (MedTech Dive)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thaysen Jacob	Chief Executive Officer	Feb 22 '24	Buy	135.29	7,330	991,672	14,861	Feb 26 08:57 AM
Hoyt Aimee L	SVP, Chief People Officer	Nov 07 '23	Sale	112.84	315	35,545	8,314	Nov 09 04:22 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Aug 22 '23	Sale	167.04	500	83,520	45,524	Aug 24 04:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your FINVIZ experience